hello, Hello, HELLO friends!
On February 27th, 2021 Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) for its single-dose COVID-19 vaccine, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson, to prevent COVID-19 in individuals 18 years of age and older. (Source: https://www.jnj.com/johnson-johnson-covid-19-vaccine-authorized-by-u-s-fda-for-emergency-usefirst-single-shot-vaccine-in-fight-against-global-pandemic). As pharmacists, your favorite 3 friends are poised to be your source of pertinent information regarding vaccine safety, efficacy, and availability. Tune in as 3 friends TALK discusses the key similarities and differences of the Johnson & Johnson vaccine compared to the Pfizer and Moderna versions. You also don’t want to miss out on Girl Talk and our signature game, this time versus Dr. Courtney, Dr. Leah and Dr. Sylvia.
Do you have questions? Shoot us a message at www.3friendsTALK.com.
